Trajectories of CD4(+)/CD8(+) T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study

The aim of the present study was to evaluate CD4/CD8 dynamics in patients on dolutegravir (DTG)-based two-drug regimens (2DRs) and compare them with DTG-containing triple-drug regimens (3DRs). A prospective observational study was performed in the context of the SCOLTA cohort. Experienced PWH with H...

Descripción completa

Detalles Bibliográficos
Autores principales: Taramasso, Lucia, Falletta, Antonio, Ricci, Elena, Orofino, Giancarlo, Squillace, Nicola, Menzaghi, Barbara, De Socio, Giuseppe Vittorio, Molteni, Chiara, Pellicanò, Giovanni Francesco, Gulminetti, Roberto, Madeddu, Giordano, Sarchi, Eleonora, Vichi, Francesca, Celesia, Benedetto Maurizio, Bonfanti, Paolo, Di Biagio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696165/
https://www.ncbi.nlm.nih.gov/pubmed/36366413
http://dx.doi.org/10.3390/v14112315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696165/
https://www.ncbi.nlm.nih.gov/pubmed/36366413
http://dx.doi.org/10.3390/v14112315

Ejemplares similares